Login
News & Updation
Best Paper Awards
World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.
Best Article of current issue
Download Article : Click here
Indexing
Abstract
WHY USFDA APPROVED HYDROXYCHLOROQUINE?
Mahesh M. Deshpande*
ABSTRACT
In the current scenario there is a severe outbreak of Coronavirus disease 2019 (COVID 2019). This outbreak started from China in December 2019.From there this infectious disease outbreaks worldwide up to April 9, 2020.The World Health Organization declares this as a worldwide pandemic. The current news shows how the infection spreads over USA, Italy and Spain, India and more than ninety countries of the world. Recently on March 28,2020 US FDA approves Hydroxychloroquine and Chloroquine for the treatment of COVID 19. There are few invitro reports are available with these antimalarial drugs that confirms the use for treatment of COVID 2019, but no evidence of clinical trials. The current viewpoint trying to explain both the situation that why these antimalarial drugs can be used for treatment and why the exclusive use should be prohibited.
[Full Text Article] [Download Certificate]